glp-1 data Receptor Agonist Market Report 2026 GLP-1 RA prescription trends: January

First, approximately 1 in 4 patients had discontinued treatment at 1 year after treatment initiation, and almost half had discontinued at 3 years, with these findings being largely similar for GLP-1 receptor agonists and SGLT2 inhibitors

Voors AA, Angermann CE, Teerlink JR, Collins SP, Kosiborod M, Biegus J, Ferreira JP, Nassif ME, Psotka MA, Tromp J, Borleffs CJW, Ma C, Comin-Colet J, Fu M, Janssens SP, Kiss RG, Mentz RJ, Sakata Y, Schirmer H, Schou M, Schulze PC, Spinarova L, Volterrani M, Wranicz JK, Zeymer U, Zieroth S, Brueckmann M, Blatchford JP, Salsali A, Ponikowski P

It is intended to reinforce provider-directed care and proper medication use

Reorder them and the result is also no longer glutathione

[1] If side effects are troublesome, discuss with your GP about potentially slowing the titration schedule